Non-inferiority of GSK Biologicals' Meningococcal Vaccine 134612 Given Concomitantly With GSK Biologicals' Twinrix Versus 134612 Alone and Twinrix Alone in Healthy Subjects Aged 11 Through 17 Years

Trial Profile

Non-inferiority of GSK Biologicals' Meningococcal Vaccine 134612 Given Concomitantly With GSK Biologicals' Twinrix Versus 134612 Alone and Twinrix Alone in Healthy Subjects Aged 11 Through 17 Years

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Dec 2016

At a glance

  • Drugs Hepatitis A-hepatitis B vaccine; Meningococcal vaccine groups A C Y W-135 conjugate
  • Indications Hepatitis A; Hepatitis B; Meningococcal infections
  • Focus Adverse reactions; Pharmacodynamics; Registrational
  • Acronyms MenACWY-TT-037
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 18 Nov 2011 Results published in Vaccine.
    • 14 Jul 2008 Actual patient number added (605) as reported by ClinicalTrials.gov.
    • 22 Apr 2008 Status changed from in progress to completed, reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top